Assembly Biosciences, Inc. (ASMB)
$20.34-10.67%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $323M
- Beta
- 1.16
- P/E (TTM)
- 36.98
- Short % float
- 32.84%
- Days to cover
- 6.8
- SI change
- +34.7%
- 1W
- -8.30%
- 1M
- -29.77%
- vs SPY 1W
- -8.72%
- vs SPY 1M
- -31.83%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on ASMB?
- LOPJLB’s latest quantitative signal on Assembly Biosciences, Inc. (ASMB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ASMB in?
- Assembly Biosciences, Inc. (ASMB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Assembly Biosciences, Inc. (ASMB) do?
- Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate, Vebicorvir, has successfully concluded Phase 2 clinical trials for individuals with chronic HBV. The company's development pipeline also features …